STAAR Surgical to Participate in Two Upcoming Investor Conferences
STAAR Surgical Company (STAA) to participate in investor meetings at Oppenheimer Healthcare MedTech & Services Conference and Sidoti Small Cap Conference. Also, meetings planned in China from March 18-20.
03/06/2024 - 07:00 AM
LAKE FOREST, Calif. --(BUSINESS WIRE)--
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that management will participate in meetings with investors at the following conferences:
Oppenheimer Healthcare MedTech & Services Conference, Tuesday, March 12
Sidoti Small Cap Conference, Wednesday, March 13
Management will also meet with investors in Shenzhen and Shanghai, China , from Monday, March 18 through Wednesday, March 20.
Investor participation is by invitation from each sponsoring brokerage firm.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™ product line. More than 2,500,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA , the company operates manufacturing and packaging facilities in Aliso Viejo, CA , Monrovia, CA and Nidau, Switzerland . For more information, please visit the Company’s website at www.staar.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240306803500/en/
Investors & Media
bmoore@staar.com
Source: STAAR Surgical Company
When will STAAR Surgical Company participate in the Oppenheimer Healthcare MedTech & Services Conference?
STAAR Surgical Company will participate in the Oppenheimer Healthcare MedTech & Services Conference on Tuesday, March 12.
What is the ticker symbol for STAAR Surgical Company?
The ticker symbol for STAAR Surgical Company is STAA.
Where will STAAR Surgical Company meet with investors in China?
STAAR Surgical Company will meet with investors in Shenzhen and Shanghai, China, from Monday, March 18 through Wednesday, March 20.
STAA Rankings
#4537 Ranked by Stock Gains
STAA Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
Country
US
City
Lake Forest
About STAA
staar surgical company (nasdaq: staa), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 30 years. the company offers the evo visian implantable collamer® lenses (icls) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and hyperopic icl, which treats far-sightedness. these lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. all of these lenses are foldable, which permits the surgeon to insert them through a small incision. staar's lens used in refractive surgery is called an implantable collamer lens or "icl". nearly 600,000 visian icls have been implanted to date. it also provides minimally invasive intraocular lenses (iols), including foldable iols for use in minimally invasive cataract surgical procedures; aspheric iols that produce a clearer image than trad
